Table 1.
Features | Percent of Population | aOR | P Value | Confidence Low | Confidence High |
---|---|---|---|---|---|
Antithrombotic use | 18.2% | 0.83 | <.05 | 0.71 | 0.97 |
Age category: | |||||
65‒69 y | 10.7% | 1.41 | <.001 | 1.06 | 1.88 |
70‒74 y | 13.1% | 1.70 | <.001 | 1.30 | 2.23 |
75‒79 y | 14.9% | 1.79 | <.001 | 1.38 | 2.34 |
80‒84 y | 14.7% | 2.42 | <.001 | 1.87 | 3.15 |
85‒89 y | 15.5% | 3.03 | <.001 | 2.35 | 3.93 |
90 y and older | 19.1% | 3.71 | <.001 | 2.89 | 4.79 |
<65 y | 12.0% | Ref | |||
Sex: | |||||
Male | 35.6% | 1.69 | <.001 | 1.49 | 1.92 |
Female | 64.4% | Ref | |||
Medical conditions: | |||||
Cancer | 12.3% | 0.72 | <.001 | 0.60 | 0.87 |
CKD | 30.3% | 1.70 | <.001 | 1.50 | 1.93 |
COPD | 48.7% | 1.07 | .280 | 0.95 | 1.20 |
CAD CHF | 42.8% | 1.13 | <.05 | 1.00 | 1.28 |
Thrombosis | 4.0% | 0.76 | .086 | 0.54 | 1.04 |
CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease.